For household contacts of individuals with COVID-19, taking ensitrelvir within 72 hours of symptoms is effective at preventing infection and generally well tolerated.

NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) has unveiled promising preclinical and Phase 1 data for ratutrelvir, its ...

The drug, ensitrelvir, is already approved in Japan to treat mild to moderate COVID cases. The SCORPIO-PEP trial, however, has demonstrated that it also has the potential to protect against illness.

“Antiviral treatments that can be taken at home to keep people with COVID-19 out of the hospital are critically needed,” Wendy Holman, chief executive officer of Ridgeback Biotherapeutics said ...

The results mean that the drug lowered the risk of getting COVID-19 by 67%. The idea of using an antiviral treatment to protect people at high risk of infection isn’t new. The popular flu treatment ...

An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on the horizon. Pfizer—the maker of Paxlovid—has begun Phase 3 ...

It is likely that COVID-19 will become a seasonal problem for years to come. For those who do become unwell, the currently available antiviral drugs are virus-specific and must be given within a ...

Japanese trading and pharmaceuticals company Kowa Co. on Monday said that anti-parasite drug ivermectin showed an "antiviral effect" against Omicron and other coronavirus variants in joint non ...

Seventeen postgraduate students have received research grants under the Post COVID-19 Skills Development and Productivity ...